-
Je něco špatně v tomto záznamu ?
Management of mild cognitive impairment (MCI): The need for national and international guidelines
S. Kasper, C. Bancher, A. Eckert, H. Förstl, L. Frölich, J. Hort, AD. Korczyn, RW. Kressig, O. Levin, MSM. Palomo
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
- MeSH
- Alzheimerova nemoc diagnóza farmakoterapie terapie MeSH
- kognitivní dysfunkce klasifikace diagnóza farmakoterapie terapie MeSH
- konsensus MeSH
- lidé MeSH
- mezinárodní spolupráce * MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- směrnice pro lékařskou praxi jako téma * MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
Objectives: To review available evidence of pharmacological and non-pharmacological treatment for MCI and analyse information and limitations in national and international guidelines.Methods: Experts from several European countries conducted a qualitative review of the literature on MCI and treatments for MCI, as well as respective chapters in national and international guidelines on dementia/MCI. Psychotherapeutic/psychosocial treatments were excluded from the review.Results: Consensus diagnostic criteria for MCI are available, making early recognition and accurate classification of MCI subtypes possible. MCI can be identified in a primary care setting. Further corroboration and differential diagnosis should be done at specialist level. Mixed pathologies are the rule in MCI, thus a multi-target treatment approach is a rational strategy. Promising evidence has been generated for multi-domain interventions. Limited evidence is available for different pharmacological classes that have been investigated in MCI clinical trials (e.g. acetylcholinesterase inhibitors). EGb 761® improved symptoms in some clinical trials; it is the only pharmacological treatment recommended in existing guidelines for the symptomatic treatment of MCI.Conclusions: MCI is recognised as an important treatment target and some recent national guidelines have considered symptomatic treatment recommendations for MCI. However, more needs to be done, especially at an international level.
Center for Brain Research Medical University of Vienna Vienna Austria
Department of Neurology Neurological Rehabilitation Landesklinikum Horn Allentsteig Horn Austria
Department of Neurology Sackler Faculty of Medicine Tel Aviv University Ramat Aviv Israel
International Clinical Research Centre Brno Czechia
Neurology Department Hospital Infanta Leonor Madrid Spain
Russian Medical Academy of Continuous Professional Education Moscow Russia
University Department of Geriatric Medicine FELIX PLATTER University of Basel Basel Switzerland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012111
- 003
- CZ-PrNML
- 005
- 20210507104852.0
- 007
- ta
- 008
- 210420s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/15622975.2019.1696473 $2 doi
- 035 __
- $a (PubMed)32019392
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kasper, Siegfried $u Center for Brain Research, Medical University of Vienna, Vienna, Austria
- 245 10
- $a Management of mild cognitive impairment (MCI): The need for national and international guidelines / $c S. Kasper, C. Bancher, A. Eckert, H. Förstl, L. Frölich, J. Hort, AD. Korczyn, RW. Kressig, O. Levin, MSM. Palomo
- 520 9_
- $a Objectives: To review available evidence of pharmacological and non-pharmacological treatment for MCI and analyse information and limitations in national and international guidelines.Methods: Experts from several European countries conducted a qualitative review of the literature on MCI and treatments for MCI, as well as respective chapters in national and international guidelines on dementia/MCI. Psychotherapeutic/psychosocial treatments were excluded from the review.Results: Consensus diagnostic criteria for MCI are available, making early recognition and accurate classification of MCI subtypes possible. MCI can be identified in a primary care setting. Further corroboration and differential diagnosis should be done at specialist level. Mixed pathologies are the rule in MCI, thus a multi-target treatment approach is a rational strategy. Promising evidence has been generated for multi-domain interventions. Limited evidence is available for different pharmacological classes that have been investigated in MCI clinical trials (e.g. acetylcholinesterase inhibitors). EGb 761® improved symptoms in some clinical trials; it is the only pharmacological treatment recommended in existing guidelines for the symptomatic treatment of MCI.Conclusions: MCI is recognised as an important treatment target and some recent national guidelines have considered symptomatic treatment recommendations for MCI. However, more needs to be done, especially at an international level.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a Alzheimerova nemoc $x diagnóza $x farmakoterapie $x terapie $7 D000544
- 650 _2
- $a kognitivní dysfunkce $x klasifikace $x diagnóza $x farmakoterapie $x terapie $7 D060825
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mezinárodní spolupráce $7 D007391
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a směrnice pro lékařskou praxi jako téma $7 D017410
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bancher, Christian $u Department of Neurology/Neurological Rehabilitation, Landesklinikum Horn-Allentsteig, Horn, Austria
- 700 1_
- $a Eckert, Anne $u Neurobiology Lab for Brain Aging and Mental Health, Transfaculty Research Platform Molecular & Cognitive Neuroscience (MCN), University of Basel, Psychiatric University Clinics Basel, Basel, Switzerland
- 700 1_
- $a Förstl, Hans $u Clinic and Polyclinic for Psychiatry and Psychotherapy, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany
- 700 1_
- $a Frölich, Lutz $u Department of Gerontopsychiatry, Central Institute of Mental Health Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
- 700 1_
- $a Hort, Jakub $u Department of Neurology, Charles University, 2nd Medical Faculty, and Motol University Hospital, Prague, Czech Republic $u International Clinical Research Centre, Brno, Czechia
- 700 1_
- $a Korczyn, Amos D $u Department of Neurology, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
- 700 1_
- $a Kressig, Reto W $u University Department of Geriatric Medicine FELIX PLATTER, University of Basel, Basel, Switzerland
- 700 1_
- $a Levin, Oleg $u Russian Medical Academy of Continuous Professional Education, Moscow, Russia
- 700 1_
- $a Palomo, María Sagrario Manzano $u Neurology Department, Hospital Infanta Leonor, Madrid, Spain
- 773 0_
- $w MED00176986 $t The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry $x 1814-1412 $g Roč. 21, č. 8 (2020), s. 579-594
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32019392 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507104850 $b ABA008
- 999 __
- $a ok $b bmc $g 1650484 $s 1132490
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 21 $c 8 $d 579-594 $e 20200205 $i 1814-1412 $m The world journal of biological psychiatry $n World J Biol Psychiatry $x MED00176986
- LZP __
- $a Pubmed-20210420